Easterly Investment Partners LLC Has $15.11 Million Stock Holdings in Elevance Health, Inc. $ELV

Easterly Investment Partners LLC increased its holdings in Elevance Health, Inc. (NYSE:ELV) by 59.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,110 shares of the company’s stock after purchasing an additional 15,998 shares during the period. Elevance Health makes up 0.9% of Easterly Investment Partners LLC’s portfolio, making the stock its 22nd biggest position. Easterly Investment Partners LLC’s holdings in Elevance Health were worth $15,112,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Physician Wealth Advisors Inc. grew its stake in Elevance Health by 331.6% during the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after buying an additional 63 shares during the last quarter. Rossby Financial LCC grew its stake in Elevance Health by 110.0% during the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after buying an additional 44 shares during the last quarter. ORG Partners LLC grew its stake in Elevance Health by 120.4% during the fourth quarter. ORG Partners LLC now owns 108 shares of the company’s stock worth $38,000 after buying an additional 59 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in Elevance Health during the fourth quarter worth about $38,000. Finally, Dorato Capital Management bought a new stake in Elevance Health during the fourth quarter worth about $41,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Bank of America raised shares of Elevance Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $405.00 to $435.00 in a research note on Wednesday, April 29th. Robert W. Baird upped their price objective on shares of Elevance Health from $317.00 to $331.00 and gave the stock a “neutral” rating in a research note on Thursday, April 23rd. Truist Financial decreased their price objective on shares of Elevance Health from $390.00 to $375.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Citigroup raised shares of Elevance Health to a “buy” rating in a research note on Wednesday, April 29th. Finally, Sanford C. Bernstein upped their price objective on shares of Elevance Health from $384.00 to $424.00 and gave the stock an “outperform” rating in a research note on Friday, April 24th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $403.11.

Elevance Health Price Performance

ELV opened at $394.40 on Monday. Elevance Health, Inc. has a one year low of $273.71 and a one year high of $408.00. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.48 and a quick ratio of 1.48. The company’s 50 day simple moving average is $343.75 and its 200-day simple moving average is $339.15. The stock has a market capitalization of $85.65 billion, a P/E ratio of 16.78, a price-to-earnings-growth ratio of 2.22 and a beta of 0.67.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating the consensus estimate of $10.74 by $1.84. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. The business had revenue of $49.49 billion for the quarter, compared to analysts’ expectations of $48.21 billion. During the same period in the prior year, the firm earned $11.97 earnings per share. Elevance Health’s revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Sell-side analysts anticipate that Elevance Health, Inc. will post 26.94 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be paid a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio is 29.26%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.